Nefiracetam is a nootropic of the racetam family. Nefiracetam is cognitive enhancer with an IC50 of approximately 150-200 μM for Ro 5-4864. This compound activates L/N-type calcium channels, cholinergic, monoaminergic and GABAergic systems. Nefiracetam displays potent neuroprotective action in the retinal ischemia-reperfusion modeProduct Display
1. It's a kind of nutritional supplement.
2. It can improve the aerobic metabolism of the muscle and greatly enhance muscle strength and endurance from diet alone.
3. It can be used as nutrition enhancer.
4. It's one of the most popular and effective nutritional supplements as well as the indispensable product for bodybuilders.
5. It is also widely used by other athletes, such as football players, basketball players and so on.
1. Memory. One of the primary Nefiracetam benefits is better memory and information retention in the long term.
2. Learning Ability. There have been studies showing that this supplement can lead to improvements in spatial learning abilities. Nefiracetam also has a much more potent effect on increasing attention spans, concentration and focus as compared to other nootropics like Pramiracetam, Oxiracetam or Piracetam.
3. Healthy Brain Cells. It may also be helpful in treating patients with cognitive decline as well as improving the health and maintenance of your brain cells. Taking Nefiracetam is thought to actually protect brain neurons from premature cell death due to cytoprotective actions.
4. Stress, Anxiety, Depression. Nefiracetam has been found useful for reducing stress, anxiety, and even depression. The mechanisms of action for these supplements are similar in many respects, but Nefiracetam seems to exhibit a wider range of effects.
5. Seizures. Studies also indicate that this supplement might be effective in treating seizures. This includes both convulsive and non-convulsive seizures. The primary effect is to greatly reduce the effects of amygdala based seizures and use for stroke patients in reducing the number and duration of post-stroke seizures.
6. Alzheimer's and Dementia. May have a therapeutic role in Alzheimer's and Dementia, but this has not been well investigated. Preliminary evidence seems promising
Мо бисёр заводҳои баландсифат дорем, ки ҳамкориҳои амиқ доранд, ки метавонанд ба шумо маҳсулоти баландсифат ва нархҳои рақобатпазирро пешниҳод кунанд. Ва мо инчунин метавонем барои хариди яклухт тахфиф диҳем. Ва мо бо бисёре аз ширкатҳои экспедитории касбӣ ҳамкорӣ карда, метавонем маҳсулотро ба дасти шумо бехатар ва осонтар расонем. Вақти таҳвил тақрибан 3-20 рӯз пас аз тасдиқи пардохт аст.
ITEM | Мушаххасоти | RESULT | METHOD |
Намуди зоҳирӣ | White powder, neutral odor, highly hygroscopic | Мутобиқ аст | Visual |
Муайянкунӣ | Standard solution and test solution same spot,RF | Мутобиқ аст | TLC |
Specific Optical | -2.4°~ -2.8° | -2.72° | |
Heavy metals (as PB) | ≤10ppm | Мутобиқ аст | AAS |
Sulfate (SO4) | ≤0.02% | Мутобиқ аст | Colorimetry |
Chloride (Cl) | ≤0.02% | Мутобиқ аст | Colorimetry |
Phosphate Ion (P) | ≤5ppm | Мутобиқ аст | Colorimetry |
Residual solvent(ethanol) | ≤1,0% | Мутобиқ аст | HS-GC |
pH | 4.5~7.0 | 5.10 | |
Related substance | Spot not bigger than standard solution spot | No spot | TLC |
Water Content | ≤2% | 0.26% | KF |
Assay (dried basis) | 98.0%--102.0% | 99.48% | Potentiometric titration |
Assay (dried basis) | 98.5%--100% | 99.2% | HPLC |
Nefiracetam belong to the non-marginal Enrichment class of drugs, these drugs have different chemical structures, both through the role of the cerebral cortex to enhance cognitive ability and prevent learning and memory damage. It does not have muscarinic receptor agonist and antagonist properties, does not inhibit the activity of Ach, the drug's anti-amnesic and memory-enhancing effect by increasing the release of cerebral cortex Ach achieved.
The memory mechanisms of nefiracetam seem to be linked back to two pathways. One is prolonging the opening of calcium channels which enhances signalling of a receptor independent of the synapse, and the other pathway seems to be tied into PKC and CAMKII which then augments signalling through cholinergic receptors. The former pathway appears to be critical for long-term potentiation, whereas the latter pathway appears to be vital for neuronal signal enhancement.
Some other minor pathways include being a partial agonist at the glycine binding site of the NDMA receptor (may enhance signalling when there are subpar levels of glycine, but attenuates excessive signalling) and increasing affinity of the muscarinic acetylcholine receptors for its ligand, acetylcholine.
1. Оё шумо корхона ё ширкати тиҷоратӣ ҳастед?
Мо як ширкате ҳастем, ки саноат ва савдоро муттаҳид карда, хидмати ягонаро пешниҳод мекунем. OEM метавонад қабул карда шавад.
2. Оё шумо намунаҳо пешниҳод мекунед? Оё он ройгон ё иловагӣ?
Намунаҳои ройгон. Пардохти боркашонии намуна бояд аз ҷониби шумо пардохт карда шавад.
3. Оё шумо ягон сертификати марбут ба назорати сифат доред?
Сертификати ISO 9001: 2008 барои таъмини сифат.
4. Барои гирифтани нархнома чиро бояд пешниҳод кунам?
Лутфан ба мо дар бораи намуди маҳсулоте, ки ба шумо лозим аст, миқдори фармоиш, суроға ва талаботи мушаххасро ба мо хабар диҳед. Иқтибос барои истинод ба шумо сари вақт дода мешавад.
5. Кадом намуди пардохти шумо бартарӣ доред? Кадом шартҳо қабул карда мешаванд?
Шартҳои қабули интиқол: FOB, CFR, CIF, EXW;
Асъори пардохти қабулшуда: доллари ИМА;
Намуди пардохти қабулшуда: T/T, Western Union; PayPal, Кафолати тиҷорат.
Забони гуфтугӯ: англисӣ.
Категорияҳои маҳсулот